The primary objective of our centre is to translate recent huge advances in the basic understanding of the pathogenesis of coeliac disease to the clinic – to improve disease diagnostics, to implement novel treatments and to identify new therapeutic targets for this common disease.
The secondary objective is to become a clinical research site at the international forefront which will provide optimal patient care and which will be a unique training site for basic scientists and clinicians.
- Author Correction: Gut microbiome structure and metabolic activity in inflammatory bowel disease Apr. 12, 2019 11:00 AM
- Epitope Selection for HLA-DQ2 Presentation: Implications for Celiac Disease and Viral Defense Mar. 31, 2019 11:00 AM
- Structural variation in the gut microbiome associates with host health Mar. 29, 2019 10:00 AM